Conference on Retrovirus and Opportunistic Infections (CROI 2026), Denver, Colorado, USA, 22-25 February 2026

Accepted as Poster presentation: 
Evaluating the impact of integrase inhibitors (INSTIs) on cardiovascular disease (CVD) will presented by  Bastian Neesgaard on behalf of the RESPOND study group